by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : October 2009
Volume 19 • Number 3 • October 2009 Australasian BioTechnology 79 AusBioPEOPLE Cincom Managing compliance as a business issue and treating regulatory requirements as an opportunity to build quality and compliance into business processes, not only reduces the risk of noncompliance, but also provides companies with a sound, cost-effective strategy for increased productivity, risk mitigation and ultimately accelerated innovation and new product introduction. Cincom ECQMS (Enterprise Compliance and Quality Management Solution) is an enterprise--wide software solution for managing corrective and preventive actions, complaint handling, change control management, internal and external audits, document control, SOP enforcement, engineering collaboration, employee certification and training, equipment/calibration, supplier quality management, advanced quality planning and risk management. This powerful solution enables you to manage quality and compliance across your entire business, helping you meet regulatory requirements, increase efficiency and reduce costs. For more information, contact Cincom Systems: Address: Level 4, Avaya Bldg., 123 Epping Road, North Ryde NSW 2113 Australia Telephone: +612 8875 1400 Fax: +612 9888 9949 Email: firstname.lastname@example.org Website: www.cincom.com.au CRC SIIB The CRC SIIB is a unique amalgamation of skill, resources, financial commitment and intellectual property from research bodies, government and the private sector. This alliance of Australia's top sugarcane biotechnology research organisations including four Universities, sugar industry research groups, CSIRO, Federal and Queensland Government and commercial expertise, is sharply focused on a bold but achievable goal -- to add new value to Australian sugarcane. The CRC SIIB's work programs are focused on three goals: To give sugarcane the ability to produce more and • better quality sucrose; To give sugarcane the ability to express alternative, • marketable products; and To attract the highest quality scientists and students, • and give them opportunities to grow with an important crop industry. For more information, visit www.crc.gov.au Contact: Julie Lloyd Communication Manager 0415 799 890 Lipotek Lipotek is an Australian start-up biotechnology company with particular interest in the development of 'targeted' therapies, particularly vaccines and immunotherapies. The discovery program is focused on products based on the Company's proprietary platform technologies and developed by way of strategic alliances with local and international pharmaceutical, governmental and non-governmental agencies. In particular, the Company has developed novel vehicles for the targeted delivery of antigens to dendritic cells (DCs) using membrane vesicles, recombinant proteins, DNA or carbohydrate-rich constructs while at the same time providing appropriate stimulatory signals to the DCs. The Lipotek lead product, Lipovaxin-MM, will enter 'First Time Into Humans' (FTIH) testing in early September 2009 when the Phase I/II clinical trial of the immunotherapy in Stage IV malignant melanoma patients is expected to begin at the Royal Adelaide Hospital. www.lipotek.com.au ABN AMRO Morgans ABN AMRO Morgans is a major supporter of the Australian life science sector. Over the last decade the firm has raised well over A$500m for over 20 life science companies. ABN AMRO Morgans has strong inhouse research and advisory capabilities, which supports an active Corporate department. ABN AMRO Morgans has over 50 offices throughout Australia which enables product to be properly and widely distributed. For more details on ABN AMRO Morgans research capabilities contact Scott Power or Tanya Solomon on +617 333 44888.